Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Busse

Showing results (11-20 of 294) with videos related to

Pageof 30
Sort By:
Health Affairs (Project Hope)|May 27, 2004
Disease management programs in Germany's statutory health insurance systemReinhard Busse
Health Economics|July 21, 2012
Do diagnosis-related groups explain variations in hospital costs and length of stay? Analyses from the EuroDRG project for 10 episodes of care across 10 European countriesReinhard Busse,
Health Policy (Amsterdam, Netherlands)|November 7, 2016
Assessing the benefit of new pharmaceuticals: Are we talking the same language, can we explain disagreement, and would it be better to do it together?Reinhard Busse
Health Policy (Amsterdam, Netherlands)|February 2, 2002
Outcome-related health targets--political strategies for better health outcomes: a conceptual and comparative study (part 2)Matthias Wismar, Reinhard Busse
Health Systems in Transition|August 14, 2014
Germany: Health system reviewReinhard Busse, Miriam Blümel
Health Policy (Amsterdam, Netherlands)|February 8, 2016
The policy contribution of the German Health Economic CentresLeonie Sundmacher, Reinhard Busse
Health Policy (Amsterdam, Netherlands)|June 21, 2016
South Korea: An interesting case to studySoonman Kwon, Reinhard Busse
Health Policy (Amsterdam, Netherlands)|February 2, 2002
Health target programmes and health care services--any link?: a conceptual and comparative study (part 1)Reinhard Busse, Matthias Wismar
Health Policy (Amsterdam, Netherlands)|December 31, 2013
Geographic variation in health care--a special issue on the 40th anniversary of "Small area variation in health care delivery"Leonie Sundmacher, Reinhard Busse
Deutsches Arzteblatt International|January 20, 2012
Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysisSandra Mangiapane, Reinhard Busse
Pageof 30

Showing results (11-20 of 294) with videos related to

Sort By:
Pageof 30
Health Affairs (Project Hope)|May 27, 2004
Disease management programs in Germany's statutory health insurance systemReinhard Busse
Health Economics|July 21, 2012
Do diagnosis-related groups explain variations in hospital costs and length of stay? Analyses from the EuroDRG project for 10 episodes of care across 10 European countriesReinhard Busse,
Health Policy (Amsterdam, Netherlands)|November 7, 2016
Assessing the benefit of new pharmaceuticals: Are we talking the same language, can we explain disagreement, and would it be better to do it together?Reinhard Busse
Health Policy (Amsterdam, Netherlands)|February 2, 2002
Outcome-related health targets--political strategies for better health outcomes: a conceptual and comparative study (part 2)Matthias Wismar, Reinhard Busse
Health Systems in Transition|August 14, 2014
Germany: Health system reviewReinhard Busse, Miriam Blümel
Health Policy (Amsterdam, Netherlands)|February 8, 2016
The policy contribution of the German Health Economic CentresLeonie Sundmacher, Reinhard Busse
Health Policy (Amsterdam, Netherlands)|June 21, 2016
South Korea: An interesting case to studySoonman Kwon, Reinhard Busse
Health Policy (Amsterdam, Netherlands)|February 2, 2002
Health target programmes and health care services--any link?: a conceptual and comparative study (part 1)Reinhard Busse, Matthias Wismar
Health Policy (Amsterdam, Netherlands)|December 31, 2013
Geographic variation in health care--a special issue on the 40th anniversary of "Small area variation in health care delivery"Leonie Sundmacher, Reinhard Busse
Deutsches Arzteblatt International|January 20, 2012
Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysisSandra Mangiapane, Reinhard Busse
Pageof 30